Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 154   

Articles published

MRK 58.58 +0.04 (0.07%)
price chart
Merck & Co. Inc. (NYSE:MRK) on Watch
[AP] Merck & Co., Inc.(NYSE:MRK) (TREND ANALYSIS), has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus.
Update: Merck & Company, Inc. Short Interest Grows by 0.3%  Stafford Daily
Share Price of Merck & Company, Inc. Rally 0.33%  Ashburn Daily
Merck & Co., Inc. Gardasil 9 Gets Green Signal From CDC Committee
Pharmaceutical giant Merck & Co., Inc. (NYSE:MRK) announced Thursday that the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) has included its Gardasil 9 vaccine in the list of recommended ...
Trade of the Day: MRK Stock Fires Off Triple Buy Signals
Merck & Co., Inc. (NYSE:MRK) - This is one of the world's largest drug manufacturers, and recent acquisitions have added to its position in niche markets.
Interesting June Stock Options for Merck
So unless Merck & Co., Inc sees its shares decline 6.4% and the contract is exercised (resulting in a cost basis of $53.89 per share before broker commissions, subtracting the $1.11 from $55), the only upside to the put seller is from collecting that ...
5 Things Merck & Co., Inc.'s Management Wants You to Know
Pharmaceutical giant Merck (NYSE: MRK ) offers a number of promising new drug candidates, but unfortunately for investors it delivered another highly forgettable quarter this past week.
Merck & Co. Inc. (MRK) Closes 0.07% Up on the Day for March 02
Merck & Co. Inc. currently has a total float of 2.85 billion shares and moves 10.06 million a day, on average. The stock opened at $58.29 on March 02 and traded between a low of $58.28 and a high of $58.89.
Merck & Co., Inc. Collaborates With MPP To Increase Access To Its HIV Drug In ...
Merck & Co., Inc. (NYSE:MRK), the second-largest US drug maker, has announced an agreement with the Medicines Patent Pool (MPP) for its HIV drug, raltegravir, in its efforts to expedite the process of developing low-priced pediatric formulations for ...
New Jersey Drugmaker Grants Free License to HIV Medicine for Children  NBC 10 Philadelphia
One Put, One Call Option To Know About for Merck & Co.
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co., Inc (NYSE: MRK). So this week we highlight one interesting put contract, and one interesting call contract, from the ...
Merck & Co. Inc. (NYSE:MRK) Partners With MPP to help Developing Countries ...
Merck & Co. Inc. (NYSE:MRK), which is the second biggest drug maker in United States, has announced that it has made an agreement with the MPP (medicine patent pool) for its HIV treatment.
Merck & Co., Inc. (MRK) Q4 Earnings Preview: Expect Lower Sales And Earnings
Merck & Co., Inc. (NYSE:MRK) is due to announce its earnings for the fourth quarter of fiscal 2014 (4QFY14) before the market opens February 4. Analysts expect the company to report $10.46 billion in revenue for the quarter, a 7.5% decline from $11.3 ...
Zacks Rating Disclosure on Merck & Co., Inc.  Stafford Daily
Merck & Co., Inc. (MRK) 4Q Results To Reflect Patents Expiry Impact  InvestCorrectly